Market Cap | 13.12M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -7.66M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -6.00% |
Sales | 88k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -16.00% |
Dividend | N/A | Price/Book | 0.70 | EPS next 5Y | - | 52W High Chg | -53.00% |
Recommedations | - | Quick Ratio | 15.50 | Shares Outstanding | 352.36M | 52W Low Chg | 101.00% |
Insider Own | 1.61% | ROA | -19.61% | Shares Float | 348.85M | Beta | 0.94 |
Inst Own | - | ROE | -61.76% | Shares Shorted/Prior | -/- | Price | 0.03 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 9,990 | Target Price | - |
Oper. Margin | -4,085.71% | Earnings Date | Aug 28 | Volume | 1,600 | Change | 0.00% |
Mountain Valley MD Holdings Inc., through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company in Canada. The company offers Quicksome oral drug formulation and delivery technologies; and Quicksol solubility formulation and delivery technology. It also provides licensed Agrarius, an agricultural plant signalling technology; and solubilized drugs to husbandry animal health. Mountain Valley MD Holdings Inc.is headquartered in Concord, Canada.